Document Classification

Section Type: RESULTS

Text: Participants taking prazosin (mean dose : 5. 7 + / - 0. 9 mg/day) had greater improvements than those taking placebo (mean dose : 5. 6 + / - 1. 2 mg/day) on the NPI (mean change : -19 + / - 21 versus -2 + / - 15, chi = 6. 32, df = 1, p = 0. 012) and BPRS (mean change : -9 + / - 9 versus -3 + / - 5, chi = 4. 42, df = 1, p = 0. 036) based on linear mixed effects models and the CGIC (mean : 2. 6 + / - 1. 0 versus 4. 5 + / - 1. 6, z = 2. 57, p = 0. 011 [Mann-Whitney test]).